Nutrien Ltd. $NTR Shares Sold by Clal Insurance Enterprises Holdings Ltd

Clal Insurance Enterprises Holdings Ltd cut its holdings in shares of Nutrien Ltd. (NYSE:NTR) by 20.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,385,282 shares of the company’s stock after selling 600,000 shares during the period. Nutrien accounts for approximately 1.0% of Clal Insurance Enterprises Holdings Ltd’s investment portfolio, making the stock its 25th biggest holding. Clal Insurance Enterprises Holdings Ltd’s holdings in Nutrien were worth $148,195,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the business. Smith Moore & CO. increased its position in shares of Nutrien by 2.2% during the third quarter. Smith Moore & CO. now owns 7,642 shares of the company’s stock worth $449,000 after purchasing an additional 168 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Nutrien by 21.8% during the fourth quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock worth $61,000 after purchasing an additional 176 shares in the last quarter. AMG National Trust Bank increased its position in shares of Nutrien by 4.0% during the third quarter. AMG National Trust Bank now owns 4,986 shares of the company’s stock worth $293,000 after purchasing an additional 193 shares in the last quarter. Bessemer Group Inc. increased its position in shares of Nutrien by 27.7% during the third quarter. Bessemer Group Inc. now owns 937 shares of the company’s stock worth $55,000 after purchasing an additional 203 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its position in shares of Nutrien by 11.5% during the fourth quarter. Farther Finance Advisors LLC now owns 2,103 shares of the company’s stock worth $130,000 after purchasing an additional 217 shares in the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Price Performance

NYSE NTR opened at $67.65 on Friday. Nutrien Ltd. has a 1 year low of $53.03 and a 1 year high of $85.36. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.24 and a quick ratio of 0.59. The company has a market cap of $32.47 billion, a price-to-earnings ratio of 13.78, a PEG ratio of 0.60 and a beta of 0.60. The stock’s fifty day moving average price is $71.34 and its 200 day moving average price is $69.17.

Nutrien (NYSE:NTR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.51 EPS for the quarter, beating the consensus estimate of $0.48 by $0.03. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The company had revenue of $6.05 billion for the quarter, compared to analyst estimates of $5.30 billion. During the same period in the prior year, the company earned $0.11 earnings per share. The firm’s revenue was up 18.5% on a year-over-year basis. As a group, equities research analysts forecast that Nutrien Ltd. will post 5.45 earnings per share for the current year.

Nutrien Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 17th. Shareholders of record on Tuesday, June 30th will be issued a $0.55 dividend. This represents a $2.20 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend is Tuesday, June 30th. Nutrien’s dividend payout ratio is presently 44.81%.

Analysts Set New Price Targets

NTR has been the topic of a number of recent analyst reports. Morgan Stanley upped their price target on Nutrien from $77.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 8th. Berenberg Bank set a $65.00 target price on Nutrien and gave the company a “hold” rating in a research report on Wednesday. BNP Paribas Exane downgraded Nutrien from an “outperform” rating to a “neutral” rating in a research report on Monday, February 23rd. Royal Bank Of Canada upped their target price on Nutrien from $80.00 to $85.00 and gave the company an “outperform” rating in a research report on Tuesday, April 7th. Finally, Canadian Imperial Bank of Commerce cut their target price on Nutrien from $90.00 to $88.00 and set an “outperformer” rating on the stock in a research report on Thursday, April 30th. Eleven equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $81.71.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.